Nonpharmacologic treatment of chronic graft-versus-host disease in children and adolescents - PubMed (original) (raw)
Review
. 2012 Jan;18(1 Suppl):S74-81.
doi: 10.1016/j.bbmt.2011.11.001.
Affiliations
- PMID: 22226116
- DOI: 10.1016/j.bbmt.2011.11.001
Free article
Review
Nonpharmacologic treatment of chronic graft-versus-host disease in children and adolescents
Anita Lawitschka et al. Biol Blood Marrow Transplant. 2012 Jan.
Free article
Abstract
Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative treatment for many children with life-threatening diseases. One of the most significant long-term complications of transplantation is chronic graft-versus-host disease (cGVHD). Although the rates of cGVHD after HSCT are lower in the pediatric population than in adults, cGVHD remains a significant cause of morbidity and mortality. Medicines used to prevent and treat cGVHD remain unsatisfactory, with protracted use of immune suppression necessary and high rates of first-line treatment failure. Efforts to improve salvage treatment are urgently required. Nonpharmacologic strategies attempt to modulate the cellular inflammation response and possibly allow reduction or cessation of immunosuppressive drugs. Mesenchymal stromal cells (MSC) have been shown in vitro to mediate a wide variety of immune responses. MSC have been used in the prophylaxis of acute GVHD (aGVHD) and for the treatment of established steroid refractory aGVHD and, more recently, in the management of cGVHD. Extracorporeal photochemotherapy (ECP) has shown promising efficacy in graft-versus-host disease, and may allow a significant reduction in the use of systemic steroids and other immunosuppressants, reducing long-term morbidity and mortality. The accumulated experience shows ECP to be well tolerated, with no clinically significant side effects.
Copyright © 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
- Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N, Donato M, Körbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P. Apisarnthanarax N, et al. Bone Marrow Transplant. 2003 Mar;31(6):459-65. doi: 10.1038/sj.bmt.1703871. Bone Marrow Transplant. 2003. PMID: 12665841 - Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J, Merlin E, Halle P, Paillard C, Marabelle A, Rapatel C, Evrard B, Berger C, Stephan JL, Galambrun C, Piguet C, D'Incan M, Bordigoni P, Deméocq F. Kanold J, et al. Transfusion. 2007 Dec;47(12):2276-89. doi: 10.1111/j.1537-2995.2007.01469.x. Epub 2007 Aug 30. Transfusion. 2007. PMID: 17764513 - Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E, Palangio M, Gonzalez J. Bisaccia E, et al. Transfus Apher Sci. 2011 Oct;45(2):187-90. doi: 10.1016/j.transci.2011.07.005. Epub 2011 Sep 3. Transfus Apher Sci. 2011. PMID: 21890415 - The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
Kaloyannidis P, Mallouri D. Kaloyannidis P, et al. Transfus Apher Sci. 2012 Apr;46(2):211-9. doi: 10.1016/j.transci.2011.10.018. Epub 2011 Nov 27. Transfus Apher Sci. 2012. PMID: 22123355 Review. - Extracorporeal photopheresis in chronic graft-versus-host disease.
Foss FM, Gorgun G, Miller KB. Foss FM, et al. Bone Marrow Transplant. 2002 May;29(9):719-25. doi: 10.1038/sj.bmt.1703529. Bone Marrow Transplant. 2002. PMID: 12040467 Review.
Cited by
- Molecular Basis beyond Interrelated Bone Resorption/Regeneration in Periodontal Diseases: A Concise Review.
Sadek KM, El Moshy S, Radwan IA, Rady D, Abbass MMS, El-Rashidy AA, Dörfer CE, Fawzy El-Sayed KM. Sadek KM, et al. Int J Mol Sci. 2023 Feb 27;24(5):4599. doi: 10.3390/ijms24054599. Int J Mol Sci. 2023. PMID: 36902030 Free PMC article. Review. - Management of Chronic Graft-vs.-Host Disease in Children and Adolescents With ALL: Present Status and Model for a Personalised Management Plan.
Sobkowiak-Sobierajska A, Lindemans C, Sykora T, Wachowiak J, Dalle JH, Bonig H, Gennery A, Lawitschka A. Sobkowiak-Sobierajska A, et al. Front Pediatr. 2022 Feb 18;10:808103. doi: 10.3389/fped.2022.808103. eCollection 2022. Front Pediatr. 2022. PMID: 35252060 Free PMC article. - [Chinese consensus on the diagnosis and management of chronic graft-versus-host disease (2021)].
Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association; China Association for the Prevention of Hematology Diseases. Hematopoietic Stem Cell Application Group, Chinese Society of Hematology, Chinese Medical Association, et al. Zhonghua Xue Ye Xue Za Zhi. 2021 Apr 14;42(4):265-275. doi: 10.3760/cma.j.issn.0253-2727.2021.04.001. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33979969 Free PMC article. Chinese. No abstract available. - Immunomodulatory Properties of Stem Cells in Periodontitis: Current Status and Future Prospective.
Wang M, Xie J, Wang C, Zhong D, Xie L, Fang H. Wang M, et al. Stem Cells Int. 2020 Jul 8;2020:9836518. doi: 10.1155/2020/9836518. eCollection 2020. Stem Cells Int. 2020. PMID: 32724318 Free PMC article. Review. - Graft-versus-host disease affecting oral cavity. A review.
Margaix-Muñoz M, Bagán JV, Jiménez Y, Sarrión MG, Poveda-Roda R. Margaix-Muñoz M, et al. J Clin Exp Dent. 2015 Feb 1;7(1):e138-45. doi: 10.4317/jced.51975. eCollection 2015 Feb. J Clin Exp Dent. 2015. PMID: 25810826 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources